M&g Investment Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by M&g Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by M&g Investment Management from 13F filings

Historical chart of M&g Investment Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by M&g Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by M&g Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $31M 18B 0.00
2023-09-30 $30M 15B 0.00

More positions owned by M&g Investment Management

Ferguson SHS
Diversified Energy Company P Shs New (DEC)
Interdigital Note 3.500% 6/0 (Principal)
Burford Cap Ord Shs (BUR)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Methanex Corp (MEOH)
Bristol Myers Squibb (BMY)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Medtronic SHS (MDT)
Nextera Energy (NEE)
V.F. Corporation (VFC)
Crown Castle Intl (CCI)
UnitedHealth (UNH)

View all positions for M&g Investment Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1